neurotypical children, and the association with autism severity
Patients start at 2.5 mg weekly for 4 weeks, then escalate by 2.5 mg increments every 4 weeks as tolerated until reaching maintenance dose, typically 10 mg or 15 mg
Carnitine Synergy is designed to address a wide spectrum of debilitating symptoms by targeting the root cause of cellular energy failure
Is it possible we are missing a treatment effect of Lixisenatide because of the heterogeneity present in most Parkinsons groups recruited for clinical trials (in other words Parkinsons is not one disease and we may have recruited a few different subtypes and this watered down the potential effects)
Short-term studies of up to 7 days have found that L-citrulline malate supplementation improves skeletal muscle metabolism and that the combination of L-citrulline and reduced glutathione (GSH) boosts plasma levels of L-citrulline, L-arginine and nitric oxide metabolites compounds that support muscle mass
Determine the appropriate concentration and dose based on your research aims